Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,971 | 340 | 85.3% |
| Travel and Lodging | $696.06 | 3 | 6.0% |
| Education | $630.92 | 7 | 5.4% |
| Consulting Fee | $397.50 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,720 | 46 | $0 (2024) |
| Axonics, Inc. | $1,442 | 13 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $849.49 | 39 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $816.59 | 20 | $0 (2024) |
| Astellas Pharma US Inc | $750.35 | 19 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $695.67 | 36 | $0 (2024) |
| PFIZER INC. | $675.46 | 26 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $585.99 | 10 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $493.02 | 2 | $0 (2023) |
| GENZYME CORPORATION | $483.74 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,483 | 109 | Axonics, Inc. ($1,271) |
| 2023 | $3,524 | 105 | Janssen Biotech, Inc. ($603.18) |
| 2022 | $2,656 | 96 | Janssen Biotech, Inc. ($348.78) |
| 2021 | $1,032 | 41 | Clarus Therapeutics Inc. ($220.76) |
All Payment Transactions
351 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/18/2024 | Azurity Pharmaceuticals, Inc. | ADTHYZA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: UROLOGY | ||||||
| 12/16/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $140.55 | General |
| Category: Urology | ||||||
| 11/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/18/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $130.35 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $93.95 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: UROLOGY | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/30/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $128.39 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/24/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.75 | General |
| 09/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: UROLOGY | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,298 | 1,875 | $282,035 | $75,637 |
| 2022 | 27 | 1,985 | 2,582 | $281,168 | $83,361 |
| 2021 | 26 | 1,137 | 1,315 | $152,184 | $47,195 |
| 2020 | 18 | 852 | 981 | $103,440 | $31,565 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 27 | 186 | $117,924 | $25,034 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 307 | $67,665 | $21,514 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 133 | $18,881 | $7,194 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $16,620 | $4,235 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 83 | $6,477 | $2,443 | 37.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 22 | $4,652 | $1,888 | 40.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $6,210 | $1,783 | 28.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $4,381 | $1,604 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 18 | $4,500 | $1,573 | 35.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 30 | $3,600 | $1,569 | 43.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 203 | 286 | $5,434 | $1,448 | 26.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 130 | 170 | $7,413 | $1,226 | 16.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 28 | 49 | $4,312 | $1,006 | 23.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 273 | 401 | $3,663 | $882.21 | 24.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 20 | $2,000 | $655.00 | 32.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $2,230 | $611.14 | 27.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 14 | $2,830 | $477.64 | 16.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 13 | $468.00 | $195.30 | 41.7% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 12 | 12 | $612.00 | $132.43 | 21.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 18 | $1,063 | $111.00 | 10.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 11 | 11 | $1,100 | $55.06 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 316 | 395 | $84,986 | $28,232 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 204 | $27,324 | $10,250 | 37.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 17 | 69 | $43,956 | $9,284 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $26,642 | $7,820 | 29.4% |
About Sarah Bartlett
Sarah Bartlett is a Adult Health healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2019. The National Provider Identifier (NPI) number assigned to this provider is 1750945234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Bartlett has received a total of $11,696 in payments from pharmaceutical and medical device companies, with $4,483 received in 2024. These payments were reported across 351 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,971).
As a Medicare-enrolled provider, Bartlett has provided services to 5,272 Medicare beneficiaries, totaling 6,753 services with total Medicare billing of $237,758. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Cary, NC
- Active Since 04/30/2019
- Last Updated 08/08/2022
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1750945234
Products in Payments
- ERLEADA (Drug) $1,744
- Axonics (Device) $1,287
- GEMTESA (Drug) $1,092
- XIAFLEX (Biological) $918.22
- PROVENGE (Drug) $816.59
- XTANDI (Drug) $610.14
- JEVTANA (Drug) $483.74
- Xtandi (Drug) $352.89
- MYRISK (Device) $338.56
- Nubeqa (Drug) $300.80
- ORGOVYX (Drug) $300.13
- JATENZO (Drug) $220.76
- LUPRON DEPOT (Drug) $213.69
- ELIGARD (Drug) $199.00
- LYNPARZA (Biological) $165.78
- PROLARIS (Device) $155.82
- Bulkamid (Device) $154.66
- PYLARIFY (Drug) $153.65
- KEYTRUDA (Biological) $141.15
- CAMCEVI (Drug) $139.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Cary
Tina Jackson, Anp, ANP
Adult Health — Payments: $1,948
Mrs. Clare Bremer, Anp-Bc, ANP-BC
Adult Health — Payments: $287.49
Elissa Poor, A-Gnp-C, A-GNP-C
Adult Health — Payments: $218.67
Barbara Kreitzer, Agnp, AGNP
Adult Health — Payments: $191.84
Mrs. Dwan Kelsey, Np, NP
Adult Health — Payments: $125.00
Megan Sneed
Adult Health — Payments: $80.83